SMYD5 and lung adenocarcinoma: In the cancer genome atlas program (TCGA) portal, SMYD5 was overexpressed in 2 types of lung cancer (lung adenocarcinoma and lung squamous cell carcinoma) samples compared to normal samples (Fig. 1A).